Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEK

NCT03553329 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT03553329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03553329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEK
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Completed
Start date
June 2, 2018
Completion date
June 2, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unresecable stage iiic or iv melanoma